179 related articles for article (PubMed ID: 25963076)
1. Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behçet's Disease in Actual Clinical Practice.
Kim B; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
Gut Liver; 2015 Nov; 9(6):750-5. PubMed ID: 25963076
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for anemia among newly-diagnosed intestinal Behcet's disease patients.
Ye JF; Chen Y; Cai JF; Shen Y; Zou J; Guan JL
J Natl Med Assoc; 2019 Aug; 111(4):407-412. PubMed ID: 30803717
[TBL] [Abstract][Full Text] [Related]
3. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors and Outcomes of Emergency Room Visits in Intestinal Behçet's Disease.
Park J; Cheon JH; Park Y; Park SJ; Kim TI; Kim WH
Digestion; 2017 Nov; 96(4):231-238. PubMed ID: 29131059
[TBL] [Abstract][Full Text] [Related]
5. Correlations between endoscopic and clinical disease activity indices in intestinal Behcet's disease.
Lee HJ; Kim YN; Jang HW; Jeon HH; Jung ES; Park SJ; Hong SP; Kim TI; Kim WH; Nam CM; Cheon JH
World J Gastroenterol; 2012 Oct; 18(40):5771-8. PubMed ID: 23155319
[TBL] [Abstract][Full Text] [Related]
6. Correlation between soluble triggering receptor expressed on myeloid cells-1 and endoscopic activity in intestinal Behçet's disease.
Lee HJ; Shin HS; Jang HW; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Yonsei Med J; 2014 Jul; 55(4):960-6. PubMed ID: 24954324
[TBL] [Abstract][Full Text] [Related]
7. Development of a Novel Endoscopic Scoring System to Predict Relapse after Surgery in Intestinal Behçet's Disease.
Park JW; Park Y; Park SJ; Kim TI; Kim WH; Cheon JH
Gut Liver; 2018 Nov; 12(6):674-681. PubMed ID: 29938457
[TBL] [Abstract][Full Text] [Related]
8. Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease.
Cheon JH; Han DS; Park JY; Ye BD; Jung SA; Park YS; Kim YS; Kim JS; Nam CM; Kim YN; Yang SK; Kim WH;
Inflamm Bowel Dis; 2011 Feb; 17(2):605-13. PubMed ID: 20848515
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
10. Serum anti-lysozyme is associated with disease activity of Behçet's disease.
Park JS; Kang MI; Ha YJ; Song JJ; Park YB; Lee SK; Lee SW
Int J Rheum Dis; 2017 Feb; 20(2):261-268. PubMed ID: 26890818
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of capsule endoscopy for detecting small bowel lesions in patients with intestinal Behçet's disease.
Arimoto J; Endo H; Kato T; Umezawa S; Fuyuki A; Uchiyama S; Higurashi T; Ohkubo H; Nonaka T; Takeno M; Ishigatsubo Y; Sakai E; Matsuhashi N; Nakajima A
Dig Endosc; 2016 Mar; 28(2):179-85. PubMed ID: 26459917
[TBL] [Abstract][Full Text] [Related]
12. Etanercept in the treatment of intestinal Behcet's disease.
Ma D; Zhang CJ; Wang RP; Wang L; Yang H
Cell Biochem Biophys; 2014 Jul; 69(3):735-9. PubMed ID: 24622940
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity.
Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA
Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease.
Chung SH; Lee HW; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Gut Liver; 2016 Jul; 10(4):574-80. PubMed ID: 26780089
[TBL] [Abstract][Full Text] [Related]
15. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
16. Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome.
Liu S; Ren J; Xia Q; Wu X; Han G; Ren H; Yan D; Wang G; Gu G; Li J
Am J Med Sci; 2013 Dec; 346(6):467-72. PubMed ID: 23689052
[TBL] [Abstract][Full Text] [Related]
17. The outcomes and risk factors of early reoperation after initial intestinal resective surgery in patients with intestinal Behçet's disease.
Park YE; Cheon JH; Park J; Lee JH; Lee HJ; Park SJ; Kim TI; Kim WH
Int J Colorectal Dis; 2017 Apr; 32(4):591-594. PubMed ID: 28028614
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of intestinal Behcet's disease during the first five years.
Jung YS; Cheon JH; Park SJ; Hong SP; Kim TI; Kim WH
Dig Dis Sci; 2013 Feb; 58(2):496-503. PubMed ID: 22899244
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet's disease.
Kang EA; Park JW; Park Y; Park SJ; Kim TI; Kim WH; Cho MS; Cheon JH
BMC Gastroenterol; 2021 Oct; 21(1):362. PubMed ID: 34620099
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet's disease.
Park J; Cheon JH; Park YE; Lee YJ; Lee HJ; Park SJ; Hong SP; Kim TI; Kim WH
Int J Colorectal Dis; 2017 May; 32(5):745-751. PubMed ID: 27924367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
